EdgarLookup

Viridian Therapeutics, Inc.\DE

VRDN NASDAQ CIK: 0001590750 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Financials Insiders

Recent Filings

All 773 filings →
Form Description Date
SCHEDULE 13G/A Mar 27, 2026
4/A 4/A Mar 9, 2026
4/A 4/A Mar 9, 2026
4/A 4/A Mar 9, 2026
4/A 4/A Mar 9, 2026
4 4 Mar 4, 2026
4 4 Mar 4, 2026
4/A 4/A Mar 4, 2026
4/A 4/A Mar 4, 2026
4 4 Mar 4, 2026

Insider Transactions

View all →
Insider Title Type Shares Date
Fairmount Healthcare Fund II GP LLC Purchase 454,545 @ $22.00 Oct 23, 2025
Beetham Thomas W. Chief Operating Officer Purchase 5,000 @ $23.41 Sep 27, 2024
Mahoney Stephen F. President and CEO Purchase 21,400 @ $23.33 Sep 27, 2024
Fairmount Healthcare Fund II L.P. Purchase 1,600,000 @ $18.75 Sep 13, 2024
Fairmount Healthcare Fund II L.P. Purchase 476,190 @ $21.00 Jan 22, 2024
Myers Scott Dunseth Chief Executive Officer Purchase 4,000 @ $25.37 Apr 12, 2023
Myers Scott Dunseth Chief Executive Officer Purchase 5,500 @ $29.15 Mar 13, 2023
Meisner Lara General Counsel and Secretary Sale 29,971 @ $29.07 Mar 9, 2023
Myers Scott Dunseth Chief Executive Officer Award / Grant 250,000 Feb 6, 2023
Violin Jonathan Chief Executive Officer Sale 50,000 @ $36.80 Feb 2, 2023